We have shown previously that DHI accelerated recovery from peripheral arterial disease in Type 2 diabetic mice by coordinated activation of VEGF/VEGFR-2 and PPARdelta pathways [24] and this action was attributable to a combined 4 active compounds in DHI [25]. The gene discussed is KDR; the disease is peripheral arterial disease.